In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Series B round brings in $15.5mm for Nodality

Executive Summary

Nodality Inc. (personalized diagnostics) raised $15.5mm through the closing of its Series B round that initially opened in 2008. Returning investor Pfizer Ventures and Laboratory Corp. of America Holdings led and were joined by additional existing backers Kleiner Perkins Caufield & Byers, TPG Biotechnology, and Maverick Capital.
Deal Industry
  • Biotechnology
    • Pharmacogenetics-Pharmacogenomics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

Advertisement
UsernamePublicRestriction

Register